UNLIMITED TURBO LONG - DOCMORRIS | Delayed Deutsche Boerse AG 15:21:14 03/06/2024 BST | ||
| 4.49 EUR | -1.97% |
|
| 1 month | -25.29% | ||
| 3 months | -27.42% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
DOCMORRIS AG
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 4.49 | -1.97% |
| 31/05/24 | 4.58 | -3.58% |
| 30/05/24 | 4.75 | +8.94% |
| 29/05/24 | 4.36 | -6.64% |
| 28/05/24 | 4.67 | +7.11% |
Delayed Quote Deutsche Boerse AG
Last update June 03, 2024 at 03:21 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | DOCMORRIS AG |
| Issuer | 
BNP Paribas
|
| WKN | PE29GD |
| ISIN | DE000PE29GD5 |
| Date issued | 03/10/2022 |
| Strike | 24.08 CHF |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.78 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.23 € |
|---|---|
| Lowest since issue | 0.24 € |
Company Profile
Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
Sector
-
Consensus: DocMorris AG
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
67.25
CHF
Average target price
99.24
CHF
Spread / Average Target
+47.57%
- Stock Market
- Certificates
- Certificat
